Impact Factor
4.33
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
6.76
3,456 total citations
h5-index
65
h5 depth signal
Cited share
77.4%
419 of 541
Total citations
3,456
Citation footprint
Metric signal
6.71
External metric anchor
Self-citation
3.7%
129 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
351
France
243
Germany
232
China
214
United Kingdom
202
Citing Fields of Research
Liver Diseases
714
Hepatitis
708
Liver & Colon Cancer
279
Immunology
152
Digestive Disorders
88
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,696
Articles tracked across the journal lifetime
Indexed publication set
541
419 cited publications
Last 12 months
391
32.6 publications/month
Open access share
100.0%
391 OA publications in the last year
Leading citing country
United States
351 citing publications
Leading citing field
Liver Diseases
714 citing publications
Latest tracked publication
16 October 2026
10 recent records available
Coverage & Indexing History
v8n1, Jan. 2026-
v1n1, May 2019-
Active Coverage
Research Focus & Classification
Indexed Subjects
Hepatitis
Liver Diseases
Liver & Colon Cancer
Issuing & Sponsoring Bodies
issuing body
European Association for the Study of the Liver
Broad Categories
Gastroenterology
Hepatitis
Liver Diseases
Liver & Colon Cancer
Immunology
MeSH Descriptors
Gastroenterology
Gastrointestinal Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1016/j.jhepr.2026.102072
Open DOI
Physical Activity and Frailty in patients with Advanced Chronic Liver Disease: A prospective study
02
DOI 10.1016/j.jhepr.2026.102058
Open DOI
Azathioprine versus mycophenolate mofetil in treatment-naive autoimmune hepatitis: 3-year follow-up of the CAMARO-trial.
03
DOI 10.1016/j.jhepr.2026.102064
Open DOI
Hippo signaling drives mesenchymal cell fate and heterogeneity in liver cancer
04
DOI 10.1016/j.jhepr.2026.102060
Open DOI
Genetic Modulation of ALT Leads to Underestimation of Liver Injury in Male ALDH2*2 Drinkers.
05
DOI 10.1016/j.jhepr.2026.102066
Open DOI
Spleen stiffness to rule out high-risk varices in advanced chronic liver disease: an individual patient data meta-analysis
06
DOI 10.1016/j.jhepr.2026.102067
Open DOI
The Liver–Heart Axis: Linking Liver Stiffness to Early Cardiac Dysfunction in MASLD
07
DOI 10.1016/j.jhepr.2026.102063
Open DOI
Hepatocellular Carcinoma Overcomes Lipid Depletion by Utilizing Serine for Phospholipid Synthesis and Enhanced Survival
08
DOI 10.1016/j.jhepr.2026.102062
Open DOI
The landscape of hepatocellular carcinoma recurrence after liver transplantation: a nationwide 14-year study
09
DOI 10.1016/j.jhepr.2026.102055
Open DOI
Hyperinflammatory Reprogramming Marks the Transition from MASH to HCC
10
DOI 10.1016/j.jhepr.2026.102059
Open DOI